Abbott Laboratories (Pakistan) (KAR:ABOT) Total Current Assets : ₨22,576 Mil (As of Mar. 2024)

View and export this data going back to 1982. Start your Free Trial

What is Abbott Laboratories (Pakistan) Total Current Assets?

Total current assets includes Cash, Cash Equivalents, Marketable Securities, Total Receivables, Total Inventories, and Other Current Assets. Abbott Laboratories (Pakistan)'s total current assets for the quarter that ended in Mar. 2024 was ₨22,576 Mil.

Abbott Laboratories (Pakistan) Total Current Assets Historical Data

The historical data trend for Abbott Laboratories (Pakistan)'s Total Current Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Abbott Laboratories (Pakistan) Total Current Assets Chart

Abbott Laboratories (Pakistan) Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Total Current Assets

Get a 7-Day Free Trial

12,337.86

15,701.74

18,432.45

21,828.89

23,199.22

Abbott Laboratories (Pakistan) Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Total Current Assets	Get a 7-Day Free Trial															24,149.51	23,489.20	26,024.23	23,199.22	22,576.12

Abbott Laboratories (Pakistan) Total Current Assets Calculation

Total Current Assets are the asset that can be converted to cash or used to pay current liabilities within 12 months.

Abbott Laboratories (Pakistan)'s Total Current Assets for the fiscal year that ended in Dec. 2023 is calculated as

Total Current Assets	=	Cash, Cash Equivalents, Marketable Securities	+	Total Receivables	+	Total Inventories	+	Other Current Assets
	=	5044.534	+	2537.862	+	13289.535	+	2327.287
	=	23,199

Abbott Laboratories (Pakistan)'s Total Current Assets for the quarter that ended in Mar. 2024 is calculated as

Total Current Assets	=	Cash, Cash Equivalents, Marketable Securities	+	Total Receivables	+	Total Inventories	+	Other Current Assets
	=	3423.253	+	4777.126	+	13126.599	+	1249.146
	=	22,576

Total Current Assets is linked to the Current Ratio, which is the result of dividing total current assets by total current liabilities. It is frequently used as an indicator of a company's liquidity, its ability to meet short-term obligations.

Total Current Assets is also linked to Working Capital, Net working capital is calculated as Total Current Assets minus Total Current Liabilities.

Abbott Laboratories (Pakistan) (KAR:ABOT) Total Current Assets Explanation

In Ben Graham's calculation of liquidation value, inventory is only considered worth half of its book value, and accounts receivable is considered worth 75% of its value. Therefore the liquidation value is lower than calculated from total current assets.

Abbott Laboratories (Pakistan)'s Liquidation Value for the quarter that ended in Mar. 2024 is

	Liquidation value
=	Cash, Cash Equivalents, Marketable Securities	-	Total Liabilities	+	(0.75 * Accounts Receivable)	+	(0.5 * Total Inventories)
=	3423.253	-	16270.292	+	0.75 * 2305.929	+	0.5 * 13126.599
=	-4,554

Abbott Laboratories (Pakistan) Total Current Assets Related Terms

Thank you for viewing the detailed overview of Abbott Laboratories (Pakistan)'s Total Current Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

Abbott Laboratories (Pakistan) (KAR:ABOT) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Abbott Laboratories (Pakistan) Ltd (KAR:ABOT) » Definitions » Total Current Assets

Comparable Companies

Traded in Other Exchanges

N/A

Address

Hyderabad Road, Landhi, P.O. Box 7229, Plot No. 258 & 324, Opposite Radio Pakistan Transmission Centre, Karachi, PAK, 75120

Website

https://www.pk.abbott

Abbott Laboratories (Pakistan) Ltd is engaged in manufacturing, importing, and marketing research-based pharmaceutical, nutritional, diagnostic, diabetes care, molecular devices, hospital, and consumer products. Its operating segments are Pharmaceutical, Nutritional, Diagnostics, and Others. It generates maximum revenue from the Pharmaceutical segment. Geographically, it derives the majority of its revenue from Pakistan and also has a presence in Afghanistan, Sri Lanka, Bangladesh, and Switzerland. Its Brands include Duphaston, Surbex Z, Serc, Duphala, Pediasur, Similac, and others.

Abbott Laboratories (Pakistan) (KAR:ABOT) Headlines

No Headlines